Multi-center phase II/III randomized controlled clinical trial using TNFerade combined with chemoradiation in patients with locally advanced pancreatic cancer (LAPC)

被引：0
|
作者：
Posner, M.
Chang, K. J.
Rosemurgy, A.
Stephenson, J.
Khan, M.
Reid, T.
Fisher, W. E.
Waxman, I.
Von Hoff, D.
Hecht, R., Jr.
机构：
[1] Univ Chicago Hosp, Chicago, IL 60637 USA
[2] Univ Calif Irvine, Orange, CA 92668 USA
[3] Univ S Florida, Tampa, FL USA
[4] Canc Ctr Carolinas, Greenville, SC USA
[5] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA
[6] Univ Calif San Diego, La Jolla, CA 92093 USA
[7] Michael E DeBakey Dept Surg, Houston, TX USA
[8] Univ Chicago, Chicago, IL 60637 USA
[9] Translat Genom Res Inst, Phoenix, AZ USA
[10] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4518
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer
    Birendra Kumar Sah
    Benyan Zhang
    Huan Zhang
    Jian Li
    Fei Yuan
    Tao Ma
    Min Shi
    Wei Xu
    Zhenglun Zhu
    Wentao Liu
    Chao Yan
    Chen Li
    Bingya Liu
    Min Yan
    Zhenggang Zhu
    Nature Communications, 11
  • [42] Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer
    Sah, Birendra Kumar
    Zhang, Benyan
    Zhang, Huan
    Li, Jian
    Yuan, Fei
    Ma, Tao
    Shi, Min
    Xu, Wei
    Zhu, Zhenglun
    Liu, Wentao
    Yan, Chao
    Li, Chen
    Liu, Bingya
    Yan, Min
    Zhu, Zhenggang
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [43] Design and methodology of LAPIS, an ongoing, phase III trial of neoadjuvant pamrevlumab (pam) with chemotherapy (CT) in patients (pts) with unresectable, locally advanced pancreatic cancer (LAPC)
    Picozzi, Vincent J.
    Raza, Syed
    Li, Jack
    Carrier, Ewa
    CANCER RESEARCH, 2023, 83 (07)
  • [44] A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer
    Patil, Prachi S.
    Saklani, Avanish
    Kumar, Naveena A. N.
    De'Souza, Ashwin
    Krishnatry, Rahul
    Khanvilkar, Snehal
    Kazi, Mufaddal
    Engineer, Reena
    Ostwal, Vikas
    Ramaswamy, Anant
    Bal, Munita
    Ranganathan, Priya
    Gupta, Ekta
    Galande, Sanjeev
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [45] High circulating CCL5 is associated with poor prognosis in locally advanced pancreatic cancer (LAPC): Biomarker analysis from the randomized phase II SCALOP trial
    Willenbrock, Frances
    Cox, Catrin
    Wilhelm-Benartzi, Charlotte
    Abraham, Aswin
    Owens, Robert
    Sabbagh, Ahmad
    Hurt, Chris
    Maughan, Tim
    O'Neill, Eric
    Mukherjee, Somnath
    CANCER RESEARCH, 2019, 79 (24)
  • [46] A randomized phase II study of gemcitabine (G) plus the cardiac glycoside huachansu (H) in the treatment of patients with locally advanced (LAPC) or metastatic pancreatic cancer (MPC).
    Meng, Z.
    Liu, L.
    Shen, Y.
    Yang, P.
    Cohen, L.
    Huo, Y.
    Zhao, Q.
    Ng, C. S.
    Chang, D. Z.
    Garrett, C. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer
    Wilson, James M.
    Fokas, Emmanouil
    Dutton, Susan J.
    Patel, Neel
    Hawkins, Maria A.
    Eccles, Cynthia
    Chu, Kwun-Ye
    Durrant, Lisa
    Abraham, Aswin G.
    Partridge, Mike
    Woodward, Martha
    O'Neill, Eric
    Maughan, Tim
    McKenna, W. Gillies
    Mukherjee, Somnath
    Brunner, Thomas B.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 (02) : 306 - 311
  • [48] A randomized phase II study of gemcitabine (G) plus the cardiac glycoside huachansu (H) in the treatment of patients with locally advanced (LAPC) or metastatic pancreatic cancer (MPC)
    Meng, Z.
    Liu, L.
    Shen, Y.
    Yang, P.
    Cohen, L.
    Huo, Y.
    Zhao, Q.
    Ng, C. S.
    Chang, D. Z.
    Garrett, C. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [49] Sorafenib improves survival in a large multi-center, randomized, placebo-controlled phase III trial in patients with hepatocellular carcinoma
    Llovet, J.
    Mazzaferro, V.
    Ricci, S.
    Hilgard, P.
    Raoul, J.
    Zeuzem, S.
    Shan, M.
    Moscovici, M.
    Voliotis, D.
    EJC SUPPLEMENTS, 2007, 5 (04): : 261 - 261
  • [50] Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer
    Vanna Chiarion-Sileni
    Roberto Innocente
    Raffaele Cavina
    Alberto Ruol
    Luigi Corti
    Jacopo Pigozzo
    Paola Del Bianco
    Uberto Fumagalli
    Armando Santoro
    Ermanno Ancona
    Cancer Chemotherapy and Pharmacology, 2009, 63
12345